Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials

@article{Wang2017RaloxifeneAA,
  title={Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials},
  author={Q. Wang and Xiaomei Dong and Y. Wang and Xiaobai Li},
  journal={Archives of Women's Mental Health},
  year={2017},
  volume={21},
  pages={31-41}
}
The aim of this study is to meta-analytically assess the efficacy and safety of adjunctive raloxifene for postmenopausal women with schizophrenia. Six studies with 440 patients, including 225 (51.14%) patients on raloxifene and 215 (48.86%) on placebo who completed 13.71 ± 5.09 weeks of treatment, were included in this study. Meta-analysis of Positive and Negative Syndrome Scale total scores and positive, negative, and general symptom scores [standard mean difference (SMD) −0.22 to −0.55, 95… Expand
8 Citations
Pharmacotherapy for schizophrenia in postmenopausal women
  • 12
Estrogens and SERMS as adjunctive treatments for schizophrenia
  • 13
Gaps or links between hormonal therapy and schizophrenia? (Review)
  • PDF
Menopause and Mental Health
  • 1

References

SHOWING 1-10 OF 69 REFERENCES
Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
  • 50
  • Highly Influential
  • PDF
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
  • 37
  • Highly Influential
  • PDF
A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.
  • 23
  • PDF
Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
  • 93
  • Highly Influential
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
  • 46
  • Highly Influential
  • PDF
Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age
  • 117
Mood effect of raloxifene in postmenopausal women.
  • 32
Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
  • 97
  • PDF
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
  • 66
Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia
  • 96
  • Highly Influential
...
1
2
3
4
5
...